Skip to main content
. 2021 Sep 13;8:702638. doi: 10.3389/fmed.2021.702638

Figure 3.

Figure 3

Development of a pyroptosis-related gene signature for breast cancer prognoses. (A) Univariate analyses were utilized for screening prognoses-related pyroptosis genes and a pyroptosis-related gene signature was established. (B) OS probabilities in high- and low-risk patients, followed by log-rank tests. (C) Distributions of IL18, GSDMC, and TIRAP expression in risk scores and different clinical features. (D) ROC curves were plotted for examining the predictive efficacy of this signature.